Despite some valuation gaps, fundamentals in key sectors such as technology and energy, in addition to country reforms, are attracting capital as optimism picks up.

The DRs represent HKEX-listed Chinese firms including Alibaba, Tencent and Xiaomi.

The private banking firm is opening new doors to growing Indian market opportunities for Indians living overseas.

Li has previously been head of Greater China for Credit Suisse and deputy head of investment banking, China, at UBS.

FinanceAsia spoke to exchange leaders about regional ESG disclosure progress and cross-border product collaboration, while the Stock Exchange of Thailand (SET) shared an exclusive update on an agreement with Indonesia and Malaysia.

The sales arm of drug maker Celltrion kicks off Korea's largest share sale this year hoping to match the success of other recent biopharma deals.

Taiwan’s Hermes Microvision and some of its pre-IPO shareholders raise $292 million, while Korea-listed Kolao and its chairman bring a $150 million deal.

A regulation prohibiting the issuance of non-capital-raising depositary receipts means India is missing out on potential foreign equity investments.

A growing litany of scandals is challenging London's position as never before. With capital fast building up in Asia itself, what role does The City have in the future?

China and India will continue to dominate DR issuance from Asia, but issuers from new markets like Vietnam and Mongolia are also likely to emerge, the bank says in a report.